This page is an automatically generated summary of information from the Federal Court, Federal Court of Appeal, Health Canada and other websites. This information should NOT be relied upon as it is automatically generated and has not been confirmed for accuracy.

Automatically generated on July 6, 2024.

Return to the list of Patented Medicine Litigation page.

---

---

Bupropion

PROLEV, QUOMEM, WELLBUTRIN SR, WELLBUTRIN XL, ZYBAN – Biovail Pharmaceuticals Canada (NOC Search)

Patents:

• 1239034: MYLAN
• 1321754: PHARMASCIENCE, SANDOZ, NOVOPHARM
• 2035893: MYLAN
• 2142320: PHARMASCIENCE, SANDOZ, MYLAN, NOVOPHARM
• 2168364: NOVOPHARM, MYLAN, PHARMASCIENCE, SANDOZ
• 2524300: ACTAVIS, RANBAXY, PHARMASCIENCE, MYLAN

ACTAVIS

• PM(NOC) – T-830-15

MYLAN

• PM(NOC) – T-1283-10
• Infringement – T-1462-11
• Impeachment – T-873-11

NOVOPHARM

• Infringement – T-1717-08
• PM(NOC) – A-39-05 – A-40-05 – T-307-04 (2009 FC 665)

PHARMASCIENCE

• PM(NOC) – T-1717-04 – T-2284-12

RANBAXY

• PM(NOC) – T-2224-16 (2018 FC 847)

SANDOZ

• PM(NOC) – T-14-05 (2007 FC 767, 2008 FC 278)

---

Return to the Patented Medicine Litigation page.